mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK

Mammalian target of rapamycin complex 1 (mTORC1) inhibitors are extensively used as immunosuppressants to prevent transplant rejection and in treatment of certain cancers. In patients, chronic treatment with rapamycin or its analogues (rapalogues) has been reported to lead to sensory hypersensitivit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Melemedjian, Ohannes K., Khoutorsky, Arkady, Sorge, Robert E., Yan, Jin, Asiedu, Marina N., Valdez, Arely, Ghosh, Sourav, Dussor, Gregory, Mogil, Jeffrey S., Sonenberg, Nahum, Price, Theodore J.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742001/
https://ncbi.nlm.nih.gov/pubmed/23607966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pain.2013.03.021
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars